MedWellAI, Inc. (MWAI) stock: key figures, P/E, revenue and dividend

Financials · United States

Price
0.30 USD
Market cap
1.31 m USD
P/E (2026)
–
P/S (2026)
2.48
Dividend yield
0.00 %
Net margin
-301.12 %
Return on equity (ROE)
19.92 %
Return on assets (ROA)
–

MedWellAI, Inc. financials

Fiscal year20252026
Revenue594,768.00 USD527,857.00 USD
Operating income-2.84 m USD-1.24 m USD
EBIT-3.73 m USD-1.54 m USD
Net income-3.61 m USD-1.59 m USD
Diluted EPS – continuing operations-0.49 USD-0.24 USD

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About MedWellAI, Inc.

MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.